The DOJ Is Letting McKinsey Opioid Consultants Off the Hook
The Biden administration’s Justice Department is allowing global consulting firm McKinsey to defer prosecution for its extensive role in fueling the opioid epidemic.

McKinsey & Company building in Toronto, Canada, on May 2, 2008. (David Cooper / Toronto Star via Getty Images)
Joe Biden’s Justice Department just handed a sweetheart deal to a global consulting firm with deep ties to the Biden administration, letting the firm off the hook for its role in helping “turbocharge” sales of the highly addictive prescription pain pill OxyContin.
The development is one of the Justice Department’s first major moves since adopting a new policy three weeks ago to go even softer on corporate crime, and will allow McKinsey & Company to defer prosecution for its extensive role in fueling the opioid epidemic that has devastated millions of American lives.
The new Justice Department policy is meant to provide leniency to corporations that cooperate with federal investigations and self-report crimes. But now McKinsey is benefiting from the new policy, even though prosecutors said that the consulting firm worked to obstruct their investigation.